These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 1259521)

  • 21. Prolactin bioassay in schizophrenia before and after neuroleptics.
    Peabody CA; Warner MD; Griffin M; Boutros NN; Worsley IG; Friesen HG
    Psychiatry Res; 1992 Mar; 41(3):249-55. PubMed ID: 1594711
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Motility, Parkinsonism, and prolactin with thiothixene and thioridazine.
    Crowley TJ; Hydinger-Macdonald M
    Arch Gen Psychiatry; 1981 Jun; 38(6):668-75. PubMed ID: 7247630
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of apomorphine on growth hormone and prolactin secretion in schizophrenic patients, with or without oral dyskinesia, withdrawn from chronic neuroleptic therapy.
    Ettigi P; Nair NP; Lal S; Cervantes P; Guyda H
    J Neurol Neurosurg Psychiatry; 1976 Sep; 39(9):870-6. PubMed ID: 993808
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patterns of psychotropic drug use for schizophrenia.
    Laska E; Varga E; Wanderling J; Simpson G; Logemann GW; Shah BK
    Dis Nerv Syst; 1973; 34(6):294-305. PubMed ID: 4782286
    [No Abstract]   [Full Text] [Related]  

  • 25. THE EFFECT OF PHENOTHIAZINES ON THE ELECTROCARDIOGRAM.
    BAN TA; STJEAN A
    Can Med Assoc J; 1964 Sep; 91(10):537-40. PubMed ID: 14176059
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased serum prolactin levels during phenothiazine and butyrophenone treatment of six postpartum women.
    Goode DJ; Meltzer HY; Fang VS
    Psychoneuroendocrinology; 1980 Dec; 5(4):345-51. PubMed ID: 6111101
    [No Abstract]   [Full Text] [Related]  

  • 27. Differential effects of neuroleptic agents on the pituitary-gonadal axis in men.
    Brown WA; Laughren TP; Williams B
    Arch Gen Psychiatry; 1981 Nov; 38(11):1270-2. PubMed ID: 6118109
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparative study of tranylcypromine and paragyline.
    Barsa JA; Saunders JC
    Psychopharmacologia; 1964 Oct; 6(4):295-8. PubMed ID: 5830807
    [No Abstract]   [Full Text] [Related]  

  • 29. Relationship of butaperazine blood levels to plasma prolactin in chronic schizophrenic patients.
    Smith RC; Tamminga CA; Crayton JW; Dekirmenjian H; Davis JM
    Psychopharmacology (Berl); 1979; 66(1):29-33. PubMed ID: 44374
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low serum neuroleptic levels predict relapse in schizophrenic patients.
    Brown WA; Laughren T; Chisholm E; Williams BW
    Arch Gen Psychiatry; 1982 Sep; 39(9):998-1000. PubMed ID: 6126172
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thiothixene versus trifluoperazine in newly-admitted schizophrenic patients.
    Bishop MP; Fulmer TE; Gallant DM
    Curr Ther Res Clin Exp; 1966 Nov; 8(11):509-14. PubMed ID: 4962777
    [No Abstract]   [Full Text] [Related]  

  • 32. A study of serum prolactin levels in schizophrenia: comparison of males and females.
    Kuruvilla A; Peedicayil J; Srikrishna G; Kuruvilla K; Kanagasabapathy AS
    Clin Exp Pharmacol Physiol; 1992 Sep; 19(9):603-6. PubMed ID: 1356671
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum prolactin levels following intramuscular chlorpromazine: two- and three-hour response as predictors of six-hour response.
    Busch DA; Fang VS; Meltzer HY
    Psychiatry Res; 1979 Oct; 1(2):153-9. PubMed ID: 45130
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum neuroleptic levels, prolactin levels, and relapse: a two-year study of schizophrenic outpatients.
    Faraone SV; Brown WA; Laughren TP
    J Clin Psychiatry; 1987 Apr; 48(4):151-4. PubMed ID: 2881923
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Research on pharmacodynamic reinforcement of neuroleptics by the 1035 M.D].
    Sizaret P; Anglade P; Simon JP
    Encephale; 1970; 59(3):278-88. PubMed ID: 5496123
    [No Abstract]   [Full Text] [Related]  

  • 36. An abnormal relation between basal prolactin levels and prolactin response to 12.5 microg TRH i.v. in drug-naïve patients with first-episode schizophrenia.
    Spoov J; Bredbacka PE; Stenman UH
    Schizophr Res; 2010 Jun; 119(1-3):41-6. PubMed ID: 20347273
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antipsychotic treatment with alpha-methyltyrosine in combination with thioridazine: prolactin response and interaction with dopaminergic precursor pools.
    Larsson M; Ohman R; Wallin L; Wålinder J; Carlsson A
    J Neural Transm; 1984; 60(2):115-32. PubMed ID: 6149256
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Basal and stimulated levels of prolactin, TSH and LH in serum of chronic schizophrenic patients, long-term treated with neuroleptics.
    Naber D; Ackenheil M; Laakman G; Fischer H; von Werder K
    Pharmakopsychiatr Neuropsychopharmakol; 1980 Nov; 13(6):325-30. PubMed ID: 6111094
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical significance of plasma chlorpromazine levels. II. Plasma levels of the drug, some of its metabolites and prolactin in patients receiving long-term phenothiazine treatment.
    Kolakowska T; Wiles DH; Gelder MG; McNeilly AS
    Psychopharmacology (Berl); 1976 Aug; 49(1):101-7. PubMed ID: 8814
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [ECG picture in the course of treatment of schizophrenia with phenothiazine derivatives].
    Welbel L; Zalewski K
    Psychiatr Pol; 1971; 5(1):49-54. PubMed ID: 5551991
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.